Literature DB >> 33664384

Detecting early myocardial ischemia in rat heart by MALDI imaging mass spectrometry.

Aleksandra Aljakna Khan1, Nasim Bararpour2,3, Marie Gorka4, Timothée Joye2,3, Sandrine Morel5, Christophe A Montessuit5, Silke Grabherr1,2, Tony Fracasso1, Marc Augsburger1,2, Brenda R Kwak5, Aurélien Thomas1,3, Sara Sabatasso6,7.   

Abstract

Diagnostics of myocardial infarction in human post-mortem hearts can be achieved only if ischemia persisted for at least 6-12 h when certain morphological changes appear in myocardium. The initial 4 h of ischemia is difficult to diagnose due to lack of a standardized method. Developing a panel of molecular tissue markers is a promising approach and can be accelerated by characterization of molecular changes. This study is the first untargeted metabolomic profiling of ischemic myocardium during the initial 4 h directly from tissue section. Ischemic hearts from an ex-vivo Langendorff model were analysed using matrix assisted laser desorption/ionization imaging mass spectrometry (MALDI IMS) at 15 min, 30 min, 1 h, 2 h, and 4 h. Region-specific molecular changes were identified even in absence of evident histological lesions and were segregated by unsupervised cluster analysis. Significantly differentially expressed features were detected by multivariate analysis starting at 15 min while their number increased with prolonged ischemia. The biggest significant increase at 15 min was observed for m/z 682.1294 (likely corresponding to S-NADHX-a damage product of nicotinamide adenine dinucleotide (NADH)). Based on the previously reported role of NAD+/NADH ratio in regulating localization of the sodium channel (Nav1.5) at the plasma membrane, Nav1.5 was evaluated by immunofluorescence. As expected, a fainter signal was observed at the plasma membrane in the predicted ischemic region starting 30 min of ischemia and the change became the most pronounced by 4 h. Metabolomic changes occur early during ischemia, can assist in identifying markers for post-mortem diagnostics and improve understanding of molecular mechanisms.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33664384      PMCID: PMC7933419          DOI: 10.1038/s41598-021-84523-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  46 in total

1.  MALDI mass spectrometric imaging of cardiac tissue following myocardial infarction in a rat coronary artery ligation model.

Authors:  Robert F Menger; Whitney L Stutts; Dhanalakshmi S Anbukumar; John A Bowden; David A Ford; Richard A Yost
Journal:  Anal Chem       Date:  2011-12-22       Impact factor: 6.986

2.  Metabolomic profile of human myocardial ischemia by nuclear magnetic resonance spectroscopy of peripheral blood serum: a translational study based on transient coronary occlusion models.

Authors:  Vicente Bodi; Juan Sanchis; Jose M Morales; Vannina G Marrachelli; Julio Nunez; Maria J Forteza; Fabian Chaustre; Cristina Gomez; Luis Mainar; Gema Minana; Eva Rumiz; Oliver Husser; Inmaculada Noguera; Ana Diaz; David Moratal; Arturo Carratala; Xavier Bosch; Angel Llacer; Francisco J Chorro; Juan R Viña; Daniel Monleon
Journal:  J Am Coll Cardiol       Date:  2012-05-01       Impact factor: 24.094

Review 3.  Ion channel macromolecular complexes in cardiomyocytes: roles in sudden cardiac death.

Authors:  Hugues Abriel; Jean-Sébastien Rougier; José Jalife
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 4.  MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice.

Authors:  Michaela Aichler; Axel Walch
Journal:  Lab Invest       Date:  2015-01-26       Impact factor: 5.662

5.  FDR-controlled metabolite annotation for high-resolution imaging mass spectrometry.

Authors:  Andrew Palmer; Prasad Phapale; Ilya Chernyavsky; Regis Lavigne; Dominik Fay; Artem Tarasov; Vitaly Kovalev; Jens Fuchser; Sergey Nikolenko; Charles Pineau; Michael Becker; Theodore Alexandrov
Journal:  Nat Methods       Date:  2016-11-14       Impact factor: 28.547

Review 6.  Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics.

Authors:  Aurélien Thomas; Sébastien Lenglet; Pierre Chaurand; Julien Deglon; Patrice Mangin; François Mach; Sabine Steffens; Jean-Luc Wolfender; Christian Staub
Journal:  Thromb Haemost       Date:  2011-05-26       Impact factor: 5.249

Review 7.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

8.  MMMDB: Mouse Multiple Tissue Metabolome Database.

Authors:  Masahiro Sugimoto; Satsuki Ikeda; Kanako Niigata; Masaru Tomita; Hideyo Sato; Tomoyoshi Soga
Journal:  Nucleic Acids Res       Date:  2011-12-01       Impact factor: 16.971

9.  Anatomical-Molecular Distribution of EphrinA1 in Infarcted Mouse Heart Using MALDI Mass Spectrometry Imaging.

Authors:  Stephan Lefcoski; Kimberly Kew; Shaun Reece; Maria J Torres; Justin Parks; Sky Reece; Lisandra E de Castro Brás; Jitka A I Virag
Journal:  J Am Soc Mass Spectrom       Date:  2018-01-05       Impact factor: 3.109

10.  Trends in mass spectrometry imaging for cardiovascular diseases.

Authors:  Stephanie T P Mezger; Alma M A Mingels; Otto Bekers; Berta Cillero-Pastor; Ron M A Heeren
Journal:  Anal Bioanal Chem       Date:  2019-04-12       Impact factor: 4.142

View more
  1 in total

Review 1.  Evolving concepts in NAD+ metabolism.

Authors:  Claudia C S Chini; Julianna D Zeidler; Sonu Kashyap; Gina Warner; Eduardo Nunes Chini
Journal:  Cell Metab       Date:  2021-04-29       Impact factor: 31.373

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.